Natural Products in Metabolic Disease Management

Summary

Natural products derived from plants, microbes and marine organisms have long served as a cornerstone in the prevention and treatment of metabolic disorders, including type 2 diabetes, dyslipidaemia and obesity. Historical successes such as statins—microbial metabolites that revolutionised cholesterol management—and biguanides, whose plant-derived precursors led to modern antidiabetic therapy, exemplify the translational potential of phytochemical discovery. Contemporary research spans isolation of polyphenols, flavonoids, triterpenoids and alkaloids, exploring their roles in modulating glucose and lipid homeostasis, reducing oxidative stress and inflammation, and targeting key enzymes. Innovations in extraction, standardisation and delivery systems have enabled the development of nutraceuticals and phytopharmaceuticals to complement conventional regimens. Advances in metabolomic profiling, structure elucidation and computational modelling are accelerating the identification of novel candidates with multitarget activity and improved safety profiles, offering promising avenues for personalised and globally accessible interventions in metabolic disease management.

Research from Nature Portfolio

No recent Nature Portfolio content available.

Natural Products in Metabolic Disease Management publication trend

The graph below shows the total number of articles in natural products in metabolic disease management across all publications each year (not limited to Nature Index journals).

Technical terms

Flavonoids: Polyphenolic compounds in plants known for antioxidant and metabolic regulatory effects.

Secoiridoids: A class of monoterpenoid glycosides often contributing to anti-inflammatory and hypoglycaemic activities.

Xanthones: Oxygenated heterocyclic compounds with diverse bioactivities including enzyme inhibition and antioxidant action.

HMG-CoA reductase: Key enzyme in cholesterol biosynthesis and principal target of statin therapy.

Antioxidant: Molecule that inhibits oxidation and mitigates oxidative stress implicated in the pathogenesis of metabolic disease.

References

  1. Natural Products to Counteract the Epidemic of Cardiovascular and Metabolic Disorders. Molecules (2016).
  2. Bioactivities of Centaurium erythraea (Gentianaceae) Decoctions: Antioxidant Activity, Enzyme Inhibition and Docking Studies. Molecules (2019).
Nature Strategy Reports
Turn complex research questions into confident strategic decisions 

When you're under pressure to set direction, justify investment, or understand your competitive position, you need more than raw data — you need trusted insights you can act on.

  • Benchmark your performance against global peers using robust, methodologically sound analysis.

  • Combine quantitative metrics with qualitative expert insight to uncover strengths, gaps and emerging opportunities.

  • Gain tailored, decision-ready recommendations aligned to your strategic priorities.

Talk to us to learn more about our data dashboards and bespoke strategy reports.

Nature Masterclasses
Grow research skills, confidence and careers with training built for every stage of the research lifecycle.

Developed with Nature Portfolio journal Editors and internationally renowned experts. Discover three ways to learn:

  • Self-paced, online courses in convenient bite-sized units, covering key skills across scientific writing, publishing, grant writing, data analysis, and more.

  • Expert trainer-led workshops with hands-on exercises and real-time feedback across core research skills, delivered via interactive group sessions.

  • Editor-led workshops combining core principles in writing and publishing, personalised 1:1 feedback from Nature Portfolio Editors and hands-on exercises.

Explore course catalogues and workshop agendas, enquire about the options or request institutional pricing.